title: Melioidosis: where do we stand in the development of an effective vaccine?
authors.affiliation: Department of Microbiology & Immunology, Institute for Translational Sciences, University of Texas Medical Branch, Galveston, TX 77555, USA.
authors.forename: Laura A
authors.initials: LA
authors.lastname: Muruato
authors.affiliation: Department of Microbiology & Immunology, Institute for Translational Sciences, University of Texas Medical Branch, Galveston, TX 77555, USA.|Sealy Center for Vaccine Development, University of Texas Medical Branch, Galveston, TX 77555, USA.
authors.forename: Alfredo G
authors.initials: AG
authors.lastname: Torres
mesh_terms: D001428:Bacterial Vaccines / Q000276:immunology* / Q000302:isolation & purification; D016957:Burkholderia pseudomallei / Q000276:immunology*; D055808:Drug Discovery / Q000639:trends*; D014943:Global Health; D006801:Humans; D008554:Melioidosis / Q000453:epidemiology / Q000517:prevention & control*
chemical_list: D001428:Bacterial Vaccines
keywords: Burkholderia pseudomallei; antigens; immune protection; melioidosis; vaccine